Search research articles
Contact Us
Filters
Showing results (91-100 of 151) with videos related to
Page
of 16
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 28, 2004
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib
Haifa-Kathrin Al-Ali, Michael Charles Heinrich, Thoralf Lange, et al.
Addiction Science & Clinical Practice
|
April 30, 2023
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches
Joanna M Streck, Susan Regan, Michael Werner, et al.
Neuro-Oncology Advances
|
February 1, 2021
Feature-based PET/MRI radiomics in patients with brain tumors
Philipp Lohmann, Anna-Katharina Meißner, Martin Kocher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and Theranostics
Jan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
Neuro-Oncology Advances
|
December 31, 2024
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with <i>IDH</i>-mutant gliomas
Norbert Galldiks, Jan-Michael Werner, Isabelle Stetter, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2019
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI
Jan-Michael Werner, Gabriele Stoffels, Thorsten Lichtenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 18, 2018
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
Philipp Lohmann, Pantelis Stavrinou, Katharina Lipke, et al.
Neuro-Oncology Advances
|
September 26, 2025
Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma
Isabelle Stetter, Jan-Michael Werner, Michael Wollring, et al.
Journal of Neuro-Oncology
|
June 18, 2022
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas
Jan-Michael Werner, Lena Wolf, Caroline Tscherpel, et al.
Scientific Reports
|
September 5, 2020
A cadaver-based biomechanical model of acetabulum reaming for surgical virtual reality training simulators
Luigi Pelliccia, Mario Lorenz, Christoph-E Heyde, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 151) with videos related to
Sort By:
Page
of 16
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 28, 2004
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib
Haifa-Kathrin Al-Ali, Michael Charles Heinrich, Thoralf Lange, et al.
Addiction Science & Clinical Practice
|
April 30, 2023
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches
Joanna M Streck, Susan Regan, Michael Werner, et al.
Neuro-Oncology Advances
|
February 1, 2021
Feature-based PET/MRI radiomics in patients with brain tumors
Philipp Lohmann, Anna-Katharina Meißner, Martin Kocher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and Theranostics
Jan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
Neuro-Oncology Advances
|
December 31, 2024
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with <i>IDH</i>-mutant gliomas
Norbert Galldiks, Jan-Michael Werner, Isabelle Stetter, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2019
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI
Jan-Michael Werner, Gabriele Stoffels, Thorsten Lichtenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 18, 2018
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
Philipp Lohmann, Pantelis Stavrinou, Katharina Lipke, et al.
Neuro-Oncology Advances
|
September 26, 2025
Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma
Isabelle Stetter, Jan-Michael Werner, Michael Wollring, et al.
Journal of Neuro-Oncology
|
June 18, 2022
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas
Jan-Michael Werner, Lena Wolf, Caroline Tscherpel, et al.
Scientific Reports
|
September 5, 2020
A cadaver-based biomechanical model of acetabulum reaming for surgical virtual reality training simulators
Luigi Pelliccia, Mario Lorenz, Christoph-E Heyde, et al.
Page
of 16